Biological preparation for treating first-class infectious viruses and preparation and application methods thereof

A technology of biological preparations and viruses, applied in the direction of antiviral agents, medical preparations containing active ingredients, pharmaceutical formulas, etc. To achieve effective treatment and block virus transmission, no toxic side effects, and prevent virus infection

Inactive Publication Date: 2021-07-23
袁月娥
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In the prior art, there is no broad-spectrum drug for the treatment of a class of infectious virus, no specific drug for the treatment of a class of infectious virus, no anti-infection drug for a class of infectious virus, and no anti-crisis drug. The existing technology used is Chinese and Western medicine treatment, Western medicine treatment, comprehensive treatment, instrument treatment, and experimental treatment. In the era of the rise of science and technology in the 21st century, the inventor used the mechanism of traditional Chinese medicine to develop a biological agent for the treatment of a class of infectious viruses to improve and beautify the living environment of human beings.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Example 1: The prevention of new coronavirus was administered to 1500 subjects, the infection rate was zero, and the immunity and physical fitness were enhanced after taking the medicine.

Embodiment 2

[0051] Example 2: Influenza-infected patients receive reagent test, the first effect of medication 2H to block transmission, headache, dizziness, runny nose, symptoms relieved, 5H symptoms of sore throat, cough, muscle pain relieved, 24H symptoms completely relieved, 48H symptoms gradually disappeared , The symptoms completely disappeared after 72 hours of medication, the spirit was restored, the infection rate of close contacts was zero, the immunity was improved, and the physical fitness was enhanced.

Embodiment 3

[0052] Example 3: Herpes zoster infection patients receive reagent test, medication 2H, the first effect of blocking transmission, skin rash subsided, pain relief, 8H symptoms continued to alleviate, 24H pain subsided, 48H rash pain symptoms continued to subside, 72H symptoms Completely subsided, the body was strengthened after one week of medication, and the infection rate of close contacts was zero.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of traditional Chinese medicines, in particular to a biological preparation for treating first-class infectious viruses. The biological preparation comprises an oral preparation, wherein the oral preparation comprises soaking powder and oral liquid; and the soaking powder is prepared from the following traditional Chinese medicine materials: moringa oleifera leaves, adenophora stricta, polygonatum odoratum, lycopodium clavatum, salvia chinensis, kadsura coccinea roots, abelmoschus esculentus, pawpaws, pine needles, lemons, longan pulps, Huoyedong, abelmoschus esculentus, stevia rebaudian, hyssop, honeysuckles, dicliptera chinensis, chrysanthemums, tea trees, hawthorns, gordon euryale seeds, lilies and fringed iris herbs; and the oral liquid is prepared from the following traditional Chinese medicine materials: cassia twigs, licorice roots, camellia japonica, abrus cantoniensis, peppermint, astragalus membranaceus, siphonostegia chinensis, cudrania cochinchinensis, leucaena indica, common perilla, phaseolus calcaratus, dendrobe, rose roots, cape jasmine, poria cocos, gynura formosana, eggplant roots, citronella, Baiduqing, turmeric and cockscomb. The biological preparation is efficient in treatment and can inhibit virus transmission according to traditional Chinese medicine pharmacological mechanism, and has a protective effect of preventing occurrence of critical diseases on patients suffering from virus-infected basic diseases.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a biological preparation for treating a class of infectious virus and its preparation and application method. Background technique [0002] Traditional Chinese medicine believes that epidemic viruses are plagues, and they have the characteristics of mass infection. The virus is caused by miasma on the surface, stagnant phase pollution, dysbiosis, and sudden outbreak of heterogeneous species. It has no root system and parasitizes. , relying on absorbing the nutrients of the ancestors as a breeding base, it has no self-reserve system and no ability to reject, so it cannot survive without the ancestors. There are many types of viruses, and different types can cause different symptoms. Some have no symptoms after infection. The symptoms of virus infection are: fever, vomiting, abdominal pain, cough, general pain, local pain, chills, palpitation, abnormal bleeding...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8969A61K36/9066A61K9/14A61K9/08A61P1/04A61P1/16A61P11/00A61P31/04A61P31/10A61P31/14A61P31/16A61P31/20A61P31/22A61K31/7052A61K31/7056A61K31/715
CPCA61K9/0095A61K9/14A61K31/7052A61K31/7056A61K31/715A61K36/076A61K36/11A61K36/15A61K36/185A61K36/19A61K36/21A61K36/23A61K36/28A61K36/287A61K36/34A61K36/342A61K36/355A61K36/36A61K36/48A61K36/481A61K36/484A61K36/534A61K36/535A61K36/537A61K36/54A61K36/57A61K36/60A61K36/61A61K36/62A61K36/73A61K36/732A61K36/734A61K36/738A61K36/744A61K36/752A61K36/77A61K36/79A61K36/80A61K36/81A61K36/82A61K36/88A61K36/8967A61K36/8969A61K36/8984A61K36/899A61K36/9066A61P1/04A61P1/16A61P11/00A61P31/04A61P31/10A61P31/14A61P31/16A61P31/20A61P31/22A61K2300/00
Inventor 袁月娥
Owner 袁月娥
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products